CorMedix (CRMD) Current Deferred Revenue (2015 - 2019)
CorMedix's (CRMD) quarterly Current Deferred Revenue came in at $2206.0 in Q4 2019, down 80.0% year-on-year from $11029.0 in Q4 2018, and down 49.86% quarter-over-quarter from $4400.0 in Q3 2019.
CorMedix (CRMD) Current Deferred Revenue (2015 - 2019) Analysis & Trends
CorMedix has disclosed Current Deferred Revenue across 5 years of filings, most recently posting $2206.0 for Q4 2019.
- Current Deferred Revenue for Q4 2019 came in at $2206.0, down 80.0% year-over-year; the trailing twelve-month figure through Dec 2019 was $2206.0 (down 80.0% YoY), and the FY2019 annual result was $2206.0, down 80.0% from the prior year.
- Current Deferred Revenue came in at $2206.0 for Q4 2019 at CorMedix, down from $4400.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $132611.0 in Q2 2016 to a low of $2206.0 in Q4 2019.
- The 5-year median for Current Deferred Revenue is $19870.0 (2016), against an average of $52911.8.
- Across the five-year window, Current Deferred Revenue surged 291.98% in 2017 and slumped 87.52% in 2018, its largest moves.
- CorMedix's Current Deferred Revenue stood at $130409.0 in 2015, then slipped by 20.09% to $104210.0 in 2016, then slipped by 15.17% to $88404.0 in 2017, then plunged by 87.52% to $11029.0 in 2018, then plunged by 80.0% to $2206.0 in 2019.
- The last three Current Deferred Revenue figures came in at $2206.0 (Q4 2019), $4400.0 (Q3 2019), and $6618.0 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 2,206.00 |
| Sep 30, 2019 | 4,400.00 |
| Jun 30, 2019 | 6,618.00 |
| Mar 31, 2019 | 8,800.00 |
| Dec 31, 2018 | 11,029.00 |
| Sep 30, 2018 | 13,235.00 |
| Jun 30, 2018 | 15,441.00 |
| Mar 31, 2018 | 17,647.00 |
| Dec 31, 2017 | 88,404.00 |
| Sep 30, 2017 | 86,600.00 |
| Jun 30, 2017 | 101,886.00 |
| Mar 31, 2017 | 101,000.00 |
| Dec 31, 2016 | 104,210.00 |
| Sep 30, 2016 | 22,093.00 |
| Jun 30, 2016 | 132,611.00 |
| Dec 31, 2015 | 130,409.00 |